Results 111 to 120 of about 839,337 (241)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Infectious Diseases of Poverty, 2022
Background Heterologous prime-boost with ChAdOx1 nCoV-19 vector vaccine (ChAd) and a messenger RNA vaccine (BNT or mRNA-1273) has been widely facilitating mass coronavirus disease 2019 (COVID-19) immunisation.
Jingjing Lv, Hui Wu, Junjie Xu, Jiaye Liu   +3 more
doaj   +1 more source

Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy [PDF]

, 2023
Background. Patients with chronic kidney disease (CKD) or kidney replacement therapy demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination compared with healthy controls. In a prospective cohort,
, Abrahams, Alferso C, Bemelman, Frederike J, Bouwmans, Pim, de Vries, Aiko P J, Gansevoort, Ron T, Hemmelder, Marc H, Hilbrands, Luuk B, Imhof, Céline, Messchendorp, A Lianne, Reinders, Marlies E J, Rispens, Theo, Sanders, Jan-Stephan F, Steenhuis, Maurice, Ten Dam, Marc A G J, van den Dorpel, René M A, Vart, Priya   +16 more
core   +1 more source

Impact of COVID‐19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza, Jose de Bessa Jr., Natássia Cristina Carboni Truzzi, Carolina Trigo Rocha, Bruno Camargo Rocha Paim de Araujo, Julyana Kanate Mazzoni Moromizato, Thulio Bosi Vieira Brandão, Rachel Mazoni Costa, Marcelo Hisano, Zein Mohamed Sammour, Homero Bruschini, William Carlos Nahas, Cristiano Mendes Gomes   +12 more
wiley   +1 more source

IMUNOGENICIDADE DE UM PRIMEIRO REFORÇO COM BNT162B2 OU MRNA-1273 DE DOSE COMPLETA: UM ESTUDO RANDOMIZADO EM ADULTOS ≥75 ANOS (EU-COVAT-1) DO CONSÓRCIO VACCELERATE

Brazilian Journal of Infectious Diseases, 2023
Introdução: A vacinação continua sendo crucial para a proteção contra a infecção grave pelo SARS-CoV-2, especialmente na população idosa. Métodos: Avaliamos, em um estudo de fase II randomizado, controlado, adaptativo e multicêntrico, a segurança e a ...
Jon Salmanton-Garcia, Julia M. Neuhann, Jannik Stemler, Antonio Carcas, Samir Kumar-Singh, Alejandro García Leon, Franz König, Oliver A. Cornely   +7 more
doaj   +1 more source

Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV [PDF]

, 2022
Concise communication[Abstract] Objective: To evaluate the safety and the serological response after two doses of mRNA-based SARS-CoV-2 vaccination in people with HIV (PWH).
Bou, Germán, Castro-Iglesias, Ángeles, Cañizares, Angelina, González de Aledo, Manuel, López, Soledad, Mena, Álvaro, Miguez, Enrique, Moldes, Luz, Vázquez-Rodríguez, Pilar   +8 more
core   +1 more source

Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe

Acta Paediatrica, EarlyView.
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner, Despina D. Briana, Gian Carlo Di Renzo   +2 more
wiley   +1 more source

Comparison of immune activation of the COVID vaccines : ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based [PDF]

, 2022
To gain insight into the different protective mechanisms of approved vaccines, this study focuses on the comparison of humoral and cellular immune responses of five widely used vaccines including ChAdOx1 (AZD1222, AstraZeneca), BNT162b2 (Pfizer), mRNA ...
Bukva Mátyás, Fodor Eszter, Földes Fanni Vivien, Hamar E, Hetényi Roland, Hinsenkamp Adél Gyöngyvér, Hornyák István, Jakab Ferenc, Kemenesi Gábor, Kuten-Pella O, Lacza Zsombor, Madár Á, Olmos Calvo I, Zana Brigitta   +13 more
core   +1 more source

Stem microanatomical phenomic uncovers a potential role for ZmLSM2 in regulating maize stem bending strength

Journal of Integrative Plant Biology, EarlyView.
Maize ZmLSM2 (U6 small nuclear ribonucleoprotein specific Sm‐like 2) controls maize stem strength by affecting vascular bundle structure. Using advanced computed tomography imaging and artificial intelligence identified key stem traits linked to lodging resistance and developed a predictive model.
Ying Zhang, Zejia Wang, Jianjun Du, Jiawen Li, Guanmin Huang, Yanxin Zhao, Yanru Wang, Qingmei Men, Minkun Guo, Minggang Zhang, Xianju Lu, Chuanyu Wang, Qikun Liu, Xinyu Guo, Chunjiang Zhao   +14 more
wiley   +1 more source

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

Nature Medicine, 2022
Rising breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in previously immunized individuals have raised concerns for the need for a booster vaccine dose to combat waning antibody levels and new variants.
L. Chu, Keith W. Vrbicky, D. Montefiori, Wenmei Huang, B. Nestorova, Ying Chang, A. Carfi, D. Edwards, J. Oestreicher, H. Legault, F. Dutko, B. Girard, R. Pajon, Jacqueline M. Miller, R. Das, B. Leav, R. McPhee   +16 more
semanticscholar   +1 more source

Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study

Clinics and Practice, 2022
Significant anti-spike protein receptor-binding domain (S-RBD) antibody responses have been demonstrated in patients with chronic disorder of consciousness (DOC) completing a COVID-19 vaccine regime with BNT162b2 (Pfizer–BioNTech). We now provide further
Maria Elena Pugliese, Riccardo Battaglia, Maria Girolama Raso, Raffaela Chiaravalloti, Francesco Coschignano, Angela Pagliuso, Roberta Bruschetta, Giovanni Pugliese, Paolo Scola, Paolo Tonin, Antonio Cerasa   +10 more
doaj   +1 more source